AAAAAA

   
Results: 1-25 | 26-50 | 51-62
Results: 1-25/62
IMPROVEMENTS IN PELVIC EXENTERATION - FACTORS RESPONSIBLE FOR REDUCING MORBIDITY AND MORTALITY
Authors: GOLDBERG JM PIVER MS HEMPLING RE AIDUK C BLUMENSON L RECIO FO
Citation: Jm. Goldberg et al., IMPROVEMENTS IN PELVIC EXENTERATION - FACTORS RESPONSIBLE FOR REDUCING MORBIDITY AND MORTALITY, Annals of surgical oncology, 5(5), 1998, pp. 399-406
CHARACTERISTICS OF OVARIES PROPHYLACTICALLY REMOVED FROM WOMEN WITH AFAMILY HISTORY OF OVARIAN-CANCER
Authors: AFIFY AM BIELAT KL ELTABBAKH GH PIVER MS PATTERSON JM WERNESS BA
Citation: Am. Afify et al., CHARACTERISTICS OF OVARIES PROPHYLACTICALLY REMOVED FROM WOMEN WITH AFAMILY HISTORY OF OVARIAN-CANCER, Modern pathology, 11(1), 1998, pp. 100-100
POORER PROGNOSIS IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER WHOSE TUMORS EXPRESS P53, BUT NOT P21(WAFL CIPL)/
Authors: WERNESS BA FREEDMAN AN PIVER MS
Citation: Ba. Werness et al., POORER PROGNOSIS IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER WHOSE TUMORS EXPRESS P53, BUT NOT P21(WAFL CIPL)/, Modern pathology, 11(1), 1998, pp. 117-117
EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA
Authors: ELTABBAKH GH PIVER MS
Citation: Gh. Eltabbakh et Ms. Piver, EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA, Oncology, 12(6), 1998, pp. 813-819
THE CLINICAL-VALUE OF DIGENE HYBRID CAPTURE HPV DNA TESTING IN A REFERRAL-BASED POPULATION WITH ABNORMAL PAP SMEARS
Authors: RECIO FO SRIVASTAVA BIS WONG C HEMPLING RE ELTABBAKH GH PIVER MS
Citation: Fo. Recio et al., THE CLINICAL-VALUE OF DIGENE HYBRID CAPTURE HPV DNA TESTING IN A REFERRAL-BASED POPULATION WITH ABNORMAL PAP SMEARS, European journal of gynaecological oncology, 19(3), 1998, pp. 203-208
PROSPECTIVE SEQUENTIAL TRIALS OF INDUCTION WEEKLY CISPLATIN FOLLOWED BY MONTHLY CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE AND PACLITAXEL ANDCISPLATIN IN OPTIMAL (LESS-THAN-OR-EQUAL-TO-1 CM) STAGE-III AND STAGE-IV OVARIAN-CANCER
Authors: PIVER MS ELTABBAKH GH HEMPLING RE RECIO FO BLUMENSON LE
Citation: Ms. Piver et al., PROSPECTIVE SEQUENTIAL TRIALS OF INDUCTION WEEKLY CISPLATIN FOLLOWED BY MONTHLY CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE AND PACLITAXEL ANDCISPLATIN IN OPTIMAL (LESS-THAN-OR-EQUAL-TO-1 CM) STAGE-III AND STAGE-IV OVARIAN-CANCER, European journal of gynaecological oncology, 19(1), 1998, pp. 5-10
LAPAROSCOPIC-ASSISTED APPLICATION OF INTERSTITIAL BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL-CARCINOMA - RESULTS OF A PILOT-STUDY
Authors: RECIO FO PIVER MS HEMPLING RE ELTABBAKH GH HAHN S
Citation: Fo. Recio et al., LAPAROSCOPIC-ASSISTED APPLICATION OF INTERSTITIAL BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL-CARCINOMA - RESULTS OF A PILOT-STUDY, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 411-414
STAGE-I ADENOCARCINOMA OF THE CERVIX - DOES LESION SIZE AFFECT TREATMENT OPTIONS AND PROGNOSIS
Authors: SILVER DF HEMPLING RE PIVER MS RECIO FO ELTABBAKH GH
Citation: Df. Silver et al., STAGE-I ADENOCARCINOMA OF THE CERVIX - DOES LESION SIZE AFFECT TREATMENT OPTIONS AND PROGNOSIS, American journal of clinical oncology, 21(5), 1998, pp. 431-435
PROGESTERONE-RECEPTOR STATUS IS A SIGNIFICANT PROGNOSTIC VARIABLE OF PROGRESSION-FREE SURVIVAL IN ADVANCED EPITHELIAL OVARIAN-CANCER
Authors: HEMPLING RE PIVER MS ELTABBAKH GH RECIO FO
Citation: Re. Hempling et al., PROGESTERONE-RECEPTOR STATUS IS A SIGNIFICANT PROGNOSTIC VARIABLE OF PROGRESSION-FREE SURVIVAL IN ADVANCED EPITHELIAL OVARIAN-CANCER, American journal of clinical oncology, 21(5), 1998, pp. 447-451
MUTATIONS IN BRCA1 FROM FIXED, PARAFFIN-EMBEDDED TISSUE CAN BE ARTIFACTS OF PRESERVATION
Authors: WONG C DICIOCCIO RA ALLEN HJ WERNESS BA PIVER MS
Citation: C. Wong et al., MUTATIONS IN BRCA1 FROM FIXED, PARAFFIN-EMBEDDED TISSUE CAN BE ARTIFACTS OF PRESERVATION, Cancer genetics and cytogenetics, 107(1), 1998, pp. 21-27
CORRELATION OF TP53 MUTATIONS AND P53 EXPRESSION IN OVARIAN-TUMORS
Authors: DICIOCCIO RA WERNESS BA PENG RQ ALLEN HJ PIVER MS
Citation: Ra. Dicioccio et al., CORRELATION OF TP53 MUTATIONS AND P53 EXPRESSION IN OVARIAN-TUMORS, Cancer genetics and cytogenetics, 105(2), 1998, pp. 93-102
AN ALTERNATIVE SPLICE-SITE JUNCTION IN EXON 1A OF THE BRCA1 GENE
Authors: FETZER S TWOREK HA PIVER MS DICIOCCIO RA
Citation: S. Fetzer et al., AN ALTERNATIVE SPLICE-SITE JUNCTION IN EXON 1A OF THE BRCA1 GENE, Cancer genetics and cytogenetics, 105(1), 1998, pp. 90-92
COMPLICATIONS RELATED TO INDWELLING CAVAL CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE
Authors: SILVER DF HEMPLING RE RECIO FO PIVER MS ELTABBAKH GH
Citation: Df. Silver et al., COMPLICATIONS RELATED TO INDWELLING CAVAL CATHETERS ON A GYNECOLOGIC ONCOLOGY SERVICE, Gynecologic oncology (Print), 70(3), 1998, pp. 329-333
CORRELATION BETWEEN EXTREME DRUG-RESISTANCE ASSAY AND RESPONSE TO PRIMARY PACLITAXEL AND CISPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER
Authors: ELTABBAKH GH PIVER MS HEMPLING RE RECIO FO LELE SB MARCHETTI DL BAKER TR BLUMENSON LE
Citation: Gh. Eltabbakh et al., CORRELATION BETWEEN EXTREME DRUG-RESISTANCE ASSAY AND RESPONSE TO PRIMARY PACLITAXEL AND CISPLATIN IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER, Gynecologic oncology (Print), 70(3), 1998, pp. 392-397
5-YEAR SURVIVAL AFTER 2ND-LINE CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER
Authors: RECIO FO PIVER MS HEMPLING RE DRISCOLL DL
Citation: Fo. Recio et al., 5-YEAR SURVIVAL AFTER 2ND-LINE CISPLATIN-BASED INTRAPERITONEAL CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 68(3), 1998, pp. 267-273
EPIDEMIOLOGIC DIFFERENCES BETWEEN WOMEN WITH EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA AND WOMEN WITH EPITHELIAL OVARIAN-CANCER
Authors: ELTABBAKH GH PIVER MS NATARAJAN N METTLIN CJ
Citation: Gh. Eltabbakh et al., EPIDEMIOLOGIC DIFFERENCES BETWEEN WOMEN WITH EXTRAOVARIAN PRIMARY PERITONEAL CARCINOMA AND WOMEN WITH EPITHELIAL OVARIAN-CANCER, Obstetrics and gynecology, 91(2), 1998, pp. 254-259
IMPORTANCE OF LYMPH-NODE METASTASES IN PRIMARY PERITONEAL CARCINOMA
Authors: ELTABBAKH GH PIVER MS HEMPLING RE WERNESS BA BLUMENSON LE
Citation: Gh. Eltabbakh et al., IMPORTANCE OF LYMPH-NODE METASTASES IN PRIMARY PERITONEAL CARCINOMA, Journal of surgical oncology, 68(3), 1998, pp. 144-148
ROLE OF PROPHYLACTIC SURGERY FOR WOMEN WITH GENETIC PREDISPOSITION TOCANCER
Authors: PIVER MS WONG C
Citation: Ms. Piver et C. Wong, ROLE OF PROPHYLACTIC SURGERY FOR WOMEN WITH GENETIC PREDISPOSITION TOCANCER, Clinical obstetrics and gynecology, 41(1), 1998, pp. 215-224
2ND-LOOK LAPAROTOMY IN ADVANCED OVARIAN-CANCER - A CRITICAL-ASSESSMENT OF MORBIDITY AND IMPACT ON SURVIVAL
Authors: HEMPLING RE WESOLOWSKI JA PIVER MS
Citation: Re. Hempling et al., 2ND-LOOK LAPAROTOMY IN ADVANCED OVARIAN-CANCER - A CRITICAL-ASSESSMENT OF MORBIDITY AND IMPACT ON SURVIVAL, Annals of surgical oncology, 4(4), 1997, pp. 349-354
SYSTEMATIC SURGICAL STAGING - STAGE-I OVARIAN-CANCER
Authors: PIVER MS
Citation: Ms. Piver, SYSTEMATIC SURGICAL STAGING - STAGE-I OVARIAN-CANCER, Journal of clinical oncology, 15(2), 1997, pp. 864-864
TUBAL-LIGATION AND THE RISK OF OVARIAN-CARCINOMA
Authors: CORNELISON TL NATARAJAN N PIVER MS METTLIN CJ
Citation: Tl. Cornelison et al., TUBAL-LIGATION AND THE RISK OF OVARIAN-CARCINOMA, Cancer detection and prevention, 21(1), 1997, pp. 1-6
EXCELLENT LONG-TERM SURVIVAL AND ABSENCE OF VAGINAL RECURRENCES IN 332 PATIENTS WITH LOW-RISK STAGE-I ENDOMETRIAL ADENOCARCINOMA TREATED WITH HYSTERECTOMY AND VAGINAL BRACHYTHERAPY WITHOUT FORMAL STAGING LYMPH-NODE SAMPLING - REPORT OF A PROSPECTIVE TRIAL
Authors: ELTABBAKH GH PIVER MS HEMPLING RE SHIN KH
Citation: Gh. Eltabbakh et al., EXCELLENT LONG-TERM SURVIVAL AND ABSENCE OF VAGINAL RECURRENCES IN 332 PATIENTS WITH LOW-RISK STAGE-I ENDOMETRIAL ADENOCARCINOMA TREATED WITH HYSTERECTOMY AND VAGINAL BRACHYTHERAPY WITHOUT FORMAL STAGING LYMPH-NODE SAMPLING - REPORT OF A PROSPECTIVE TRIAL, International journal of radiation oncology, biology, physics, 38(2), 1997, pp. 373-380
THE ADDITION OF BLEOMYCIN AND DOSE-ESCALATED IFOSFAMIDE TO THE COMBINATION OF CISPLATIN PLUS IFOSFAMIDE DOES NOT IMPROVE SURVIVAL IN ADVANCED OR RECURRENT CERVICAL-CARCINOMA
Authors: HEMPLING RE ELTABBAKH GH PIVER MS RECIO FO ONEILL CP
Citation: Re. Hempling et al., THE ADDITION OF BLEOMYCIN AND DOSE-ESCALATED IFOSFAMIDE TO THE COMBINATION OF CISPLATIN PLUS IFOSFAMIDE DOES NOT IMPROVE SURVIVAL IN ADVANCED OR RECURRENT CERVICAL-CARCINOMA, American journal of clinical oncology, 20(3), 1997, pp. 315-318
EXPRESSION OF THE P53 INDUCED TUMOR-SUPPRESSOR P21(WAF1 CIP1) IN OVARIAN CARCINOMAS - CORRELATION WITH P53 AND KI-67 IMMUNOHISTOCHEMISTRY/
Authors: WERNESS BA JOBE JS DICIOCCIO RA PIVER MS
Citation: Ba. Werness et al., EXPRESSION OF THE P53 INDUCED TUMOR-SUPPRESSOR P21(WAF1 CIP1) IN OVARIAN CARCINOMAS - CORRELATION WITH P53 AND KI-67 IMMUNOHISTOCHEMISTRY/, International journal of gynecological pathology, 16(2), 1997, pp. 149-155
PROPHYLACTIC OOPHORECTOMY - A CENTURY LONG DILEMMA
Authors: PIVER MS WONG C
Citation: Ms. Piver et C. Wong, PROPHYLACTIC OOPHORECTOMY - A CENTURY LONG DILEMMA, Human reproduction, 12(2), 1997, pp. 205-206
Risultati: 1-25 | 26-50 | 51-62